Terkko Navigator / Nephrology/ Feeds

Life Expectancy in Men with Prostate Cancer.

Reply to Letter to the Editor Re: External Validation of the Prostate Cancer-specific Comorbidity Index (PCCI), a Claims-Based Tool for Prediction of Life Expectancy in Men with Prostate Cancer.

Prostate Cancer Detection Rate of Free-hand versus 3D Template Mapping Biopsy Using an MRI/Ultrasound Fusion Device in Biopsy-Naive Men.

Local Recurrence Following Resection of Intermediate-High Risk Non-metastatic Renal Cell Carcinoma: An Anatomic Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial.

Prognosis of the 8th TNM Staging System for Penile Cancer and Refinement of Prognostication by Incorporating hrHPV Status.

Association Between Development of Metabolic Acidosis and Improvement of Urinary Continence after Ileal Neobladder Creation.

Valuation of lymph node dissection in localized high-risk renal cell cancer using X-tile software

Thiazide-Associated Hyponatremia: Clinical Manifestations and Pathophysiology.

Diagnosis and Management of Disorders of Body Tonicity-Hyponatremia and Hypernatremia: Core Curriculum 2020.

Genetics and ESKD Disparities in African Americans.

Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.

Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe.

Time to Reconsider Calcium-Based Phosphate Binders in Dialysis? A Call for a Well-Designed Randomized Controlled Trial.

Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis.

Health Outcomes and Health Care Utilization Among Obstetric Deliveries With Concurrent CKD in the United States.

Trends in Mortality Among Patients Initiating Maintenance Dialysis in Puerto Rico Compared to US States, 2006-2015.

Nomograms for predicting long-term overall survival and cancer-specific survival in patients with primary urethral carcinoma: a population-based study

Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study

Selective Arterial Embolization for Large or Symptomatic Renal Angiomyolipoma: 10 Years of Follow-Up

Variable Use of Postoperative Imaging Following Ureteroscopy: Results from a Statewide Quality Improvement Collaborative

A population-based study of ureteroenteric strictures after open and robot-assisted radical cystectomy

Reliability of thermocautery-assisted circumcision: retrospective analysis of circumcision performed voluntarily in countries of low socioeconomic status

Prognostic value of PD-L1 expression for surgically treated localized renal cell carcinoma: implications for risk stratification and adjuvant therapies

Incorporating mpMRI biopsy data into established pre-RP nomograms: potential impact of an increasingly common clinical scenario

Sclerostin: a new biomarker of CKD–MBD

Re: Partial Nephrectomy Versus Radical Nephrectomy for cT2 or Greater Renal Tumors: A Systematic Review and Meta-analysis

Clinical Acumen Versus Androgen Receptor Variant 7 Circulating Tumor Cells in Decision-Making for Men with Advanced Prostate Cancer

Another Tool in the Fight Against Phosphate Toxicity: Where Will It Fit and What Does It Tell Us about Phosphate Homeostasis?

In Remembrance of Thomas F. Ferris, MD, Former ASN President (1987-1988).

Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus.

The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants

Climbing over the Barriers of Current Imaging Technology in Urology

Re: Laurence Albiges, Tom Powles, Michael Staehler, et al. Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-Cell Renal Cell Carcin

APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI).

Preoperative Risk Assessment and Management in Adults Receiving Maintenance Dialysis and Those With Earlier Stages of CKD.

New Ways of Finding New Genes for Old Diseases.

Diagnostic utility of penile ultrasound in Peyronie’s disease

Safety, feasibility, and efficacy of early rehabilitation in patients requiring continuous renal replacement: A quality improvement study

Nephrotoxic medications and acute kidney injury risk factors in the neonatal intensive care unit: clinical challenges for neonatologists and nephrologists

Managing lines of therapy in castration-resistant prostate cancer: real-life snapshot from a multicenter cohort

WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH

Class Effect: Dapagliflozin Reduces Cardiovascular and Kidney Events

Glycogen synthase kinase 3β hyperactivity in urinary exfoliated cells predicts progression of diabetic kidney disease.

Mast cell chymase protects against acute ischemic kidney injury by limiting neutrophil hyperactivation and recruitment

Potassium Homeostasis and Management of Dyskalemia in Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Studying the Renoprotective Effects of Dapagliflozin in type 2 diabetes

Re: Lorenzo Marconi, Thomas Stonier, Rafael Tourinho-Barbosa, et al. Robot-assisted Radical Prostatectomy After Focal Therapy: Oncological, Functional Outcomes and Predictors of Recurrence. Eur Urol 2019;76:27–30: Salvage Robotic Radical Prostatectom

Re: Long-term Outcomes for Men in a Prostate Screening Trial with an Initial Benign Prostate Biopsy: A Population-based Cohort

Reply to Liang Sun and Yi Feng’s Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for St

Re: Jack R. Andrews, Thomas Atwell, Grant Schmit, et al. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2019;76:244–51